Amedisys Inc (AMED)
NASDAQ:AMED
Holding AMED?
Track your performance easily

Amedisys (AMED) Technical Analysis

443 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Amedisys Inc’s (AMED) Moving Averages Convergence Divergence (MACD) indicator is -0.14, suggesting Amedisys Inc is a Buy.
Amedisys Inc’s (AMED) 20-Day exponential moving average is 97.34, while Amedisys Inc’s (AMED) share price is $97.21, making it a Sell.
Amedisys Inc’s (AMED) 50-Day exponential moving average is 97.05, while Amedisys Inc’s (AMED) share price is $97.21, making it a Buy.

Amedisys (AMED) Pivot Points

Sep 20, 2024, 12:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
96.36
96.56
96.97
97.17
97.58
97.78
98.19
Fibonacci
96.56
96.80
96.94
97.17
97.41
97.55
97.78
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Amedisys (AMED) Moving Averages

Sep 20, 2024, 12:27 AM
Period
Simple
Exponential
MA5
97.03Buy
97.12Buy
MA10
97.10Buy
97.18Sell
MA20
97.41Sell
97.34Sell
MA50
97.73Sell
97.05Buy
MA100
95.71Buy
96.10Buy
MA200
94.61Buy
95.09Buy
Amedisys Inc’s (AMED) 10-Day exponential moving average is 97.18, while Amedisys Inc’s (AMED) share price is $97.21, making it a Sell.
Amedisys Inc’s (AMED) 100-Day exponential moving average is 96.10, while Amedisys Inc’s (AMED) share price is $97.21, making it a Buy.
Amedisys Inc’s (AMED) stock price is $97.21 and Amedisys Inc’s (AMED) 50-day simple moving average is 97.73, creating a Sell signal.
Amedisys Inc’s (AMED) stock price is $97.21 and Amedisys Inc’s (AMED) 100-day simple moving average is 95.71, creating a Buy signal.
Amedisys Inc’s (AMED) stock price is $97.21 and Amedisys Inc’s (AMED) 200-day simple moving average is 94.61, creating a Buy signal.

Amedisys (AMED) Technical Indicators

Sep 20, 2024, 12:27 AM
Name
Value
Implied Action
RSI (14)
46.62
Neutral
STOCH (9,6)
50.73
Neutral
STOCHRSI (14)
39.01
Neutral
MACD (12,26)
-0.14
Buy
ADX (14)
21.76
Neutral
Williams %R
-60.57
Buy
CCI (14)
-62.68
Neutral
ATR (14)
0.52
-
Ultimate Oscillator
51.96
Neutral
ROC
-0.77
Sell
Amedisys Inc’s (AMED) Relative Strength Index (RSI) is 46.62, creating a Neutral signal.
Amedisys Inc’s (AMED) Trend Strength Indicator (ADX) is 21.76, creating a Neutral signal.
Amedisys Inc’s (AMED) Commodity Channel Index (CCI) is -62.68, creating a Neutral signal.
Amedisys Inc’s (AMED) Price Rate of Change (ROC) is -0.77, creating a Sell signal.

FAQ

Is AMED a Buy, Hold, or Sell?
Based on AMED’s technical indicators, AMED is a Buy.
    What is AMED’s RSI (14)?
    AMED’s RSI (14) is 46.62, which suggests AMED is a Neutral.
      What is AMED’s MACD?
      AMED’s MACD is -0.14, which suggests AMED is a Buy.
        What is AMED’s 5-day moving average?
        AMED’s 5-day moving average is 97.03, which suggests AMED is a Buy.
          What is AMED’s 20-day moving average?
          AMED 20-day moving average is 97.41, which suggests AMED is a Sell.
            What is AMED’s 50-day moving average?
            AMED’s 50-day moving average is 97.73, which suggests AMED is a Sell.
              What is AMED’s 200-day moving average?
              AMED’s 200-day moving average is 94.61, which suggests AMED is a Buy.
                What is AMED’s Williams % R (14)?
                AMED’s Williams % R (14) is -60.57, which suggests AMED is a Buy.
                  What is AMED’s CCI (14)?
                  AMED’s CCI (14) is -62.68, which suggests AMED is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis